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Abstract
Procedures for producing and exploringTrypanosoma cruzi farnesyl pyrophosphate
synthase (tcFPPS) for surface plasmon resonance (SPR) biosensor-driven fragment-
based discovery have been established. The method requires functional sensor sur-
faces with high sensitivity for extended times and appropriate controls. Initial prob-
lems with protein stability and lack of useful reference compounds motivated
optimization of experimental procedures and conditions. The improved methods
enabled the production of pure, folded and dimeric protein, and identified proce-
dures for storage and handling. A new coupled enzymatic assay, using luciferase for
detection of pyrophosphate, was developed and used to confirm that the purified
enzyme was active after purification and storage. It also confirmed that sensor sur-
faces prepared with structurally intact protein was active. An SPR-biosensor assay
for fragment library screening and hit confirmation was developed. A thermal shift
assaywas used in parallel. A library of 90 fragments was efficiently screened by both
assays at a single concentration in the presence and absence of the catalytic cofactor
Mg2+. Hits were selected on the basis of response levels orΔTm > 1C and selectiv-
ity for tcFPPS in the presence of Mg2+. Characterization of hits by SPR showed that
all had low affinities and the relationships between steady-state responses and con-
centrationswere not sufficiently hyperbolic for determination of KD-values. Instead,
ranking could be performed from the slope of the linear relationship at low concen-
trations. This pilot screen confirms that the procedures developed herein enables
SPR-biosensor driven fragment-based discovery of leads targeting tcFPPS, despite
the lack of a reference compound.
Significance Statement: To enable the discovery of drugs, it is essential to
have access to relevant forms of the target protein and valid biochemical
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methods for studying the protein and effects of compounds that may be
evolved into drugs. We have established methods for the discovery of drugs for
treatment of American Trypanosomiasis (Chagas disease), using farnesyl
pyrophosphate synthase from Trypanosoma cruzi as a target.
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1 | INTRODUCTION
American Trypanosomiasis, known also as Chagas disease,
is a neglected tropical disease caused by the protozoan para-
site Trypanosoma cruzi. Current treatments for Chagas dis-
ease are around 40 years old and suffer from long regimens
and difficulties in assessing their efficacy for patients in a
chronic stage of infection.1 However, recent studies of the
parasite have identified several targets for new drugs. Our
focus is on farnesyl pyrophosphate synthase (FPPS, EC
2.5.1.10), a key enzyme in the mevalonate pathway. It cat-
alyzes the condensation of isoprenyl pyrophosphate (IPP)
with dimethylallyl pyrophosphate and with geranyl
diphosphate (GPP), essential components for the viability
also of Trypanosoma species.2 FPPS has been proposed as
a suitable molecular target for drug development.3 Nitro-
gen containing bisphosphonates, such as risendronate,
have antiproliferative and cytocidal effects against T. cruzi,
resulting from blocking isoprenoid synthesis at the level of
FPPS.4–6 Current efforts are mainly focused on the
improvement of bisphosphonates in order to increase their
specificity for the parasitic enzyme.7,8 Our aim is to facili-
tate a broader approach in the discovery of drugs by devel-
oping effective methods that can identify inhibitors with
new scaffolds and/or other modes of action, and with a
high potential for efficient and safe drugs.
Fragment-based lead discovery (FBLD) is a relatively
fast and cost-efficient approach for identifying new leads.
The rationale is to use sensitive biophysical methods to
screen compound libraries of low molecular mass “frag-
ments” (< 300 Da) for candidates that interact with the
target, and to subsequently evolve them into drug leads
by structure-guided optimization.9,10 Due to the size of
fragments, chemical space can be efficiently sampled
using libraries containing few (<2000) but structurally
diverse compounds. A major challenge is that fragments
typically have very weak affinities for the target of inter-
est and screening methods with a very high sensitivity
are required.11 Success is typically a result of high-
quality preparations of the target protein (not necessar-
ily large quantities) and an extensive understanding of
its physicochemical properties under various conditions.
Consequently, a range of biophysical and biochemical
methods, target variants and tool compounds, are
required for validating the quality of the target sample
and for exploring various experimental design strategies.
For the discovery of new leads targeting FPPS, we
selected a surface plasmon resonance (SPR) biosensor-
based strategy. SPR is one of the most used biophysical
techniques in fragment-based screening and lead optimi-
zation. The technology is based on the detection of the
binding between a surface-immobilized molecule (such
as a protein) and a molecule in solution (such as a frag-
ment). A major challenge for SPR-based screening and
lead discovery is the immobilization of a fully functional
target on a sensor chip and to keep it functionally stable
over the time under the conditions required for experi-
ments (typically days and room temperature). This is par-
ticularly critical for screening of fragment libraries due to
the typically weak affinities of hits. They often interact
nonspecifically, that is, at multiple sites of the target pro-
teins, even when the protein is not correctly folded. It is
consequently essential that the target protein is of high
quality and that experimental conditions for its handling
are under control before performing SPR experiments.
This requires expertise and experience in protein produc-
tion and assessment of the structural integrity
(e.g., folding and homogeneity) and functionality of the
target (e.g., catalytic activity of enzymes), as well as in
how to set up high-quality assays with suitable analysis
protocols.12 Reference compounds with known interaction
features are used to confirm that sensor surfaces are func-
tional and identified hits interact in the expected manner,
taking into account how known references interact.
The cloning and overexpression of Trypanosoma cruzi
farnesyl pyrophosphate synthase (tcFPPS) in bacteria
(E. coli) was reported for the first time in 2001.4 The same
study included a purification protocol and activity assay
based on radiometric end point measurements.13 The
expression/purification and storage conditions described in
the initial publication have been repeated successfully in
other studies,14–16 although authors have stated that
they encountered some stability issues with the crystal-
lization of the protein.16 From our own experience, the
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protein we initially produced using a very similar
approach was unstable and lost functionality over time.
It was therefore not of sufficient quality for SPR experi-
ments, especially not for fragment screening. Here,
we describe modified expression and storage conditions
that enabled the production of high levels of high-quality
protein that could tolerate long-term storage. We also
describe orthogonal procedures for evaluation of both the
structural integrity and the activity of tcFPPS. A screen of
a small fragment library, using SPR biosensor and ther-
mal shift assays, validated that the produced protein met
the requirements for SPR-driven FBLD.
2 | RESULTS
2.1 | Production of recombinant tcFPPS
tcFPPS with an N-terminal His-tag was recombinantly
produced in Escherichia coli and purified by Ni2+-IMAC.
The purified protein was >90% pure, as estimated by
sodium dodecyl sulfate polyacrylamide electrophoresis
(SDS-PAGE) analysis. The final concentration was
7 mg/mL in a total volume of 4.5 mL, giving a total yield
of around 30 mg/L of culture.
2.2 | Thermal stability of recombinant
tcFPPS under different conditions
Experiments with the tcFPPS initially produced, essentially
according to a published protocol,14 indicated that the puri-
fied protein was unstable and lost functionality over time. It
was therefore necessary to optimize the buffers used for stor-
age and subsequent experiments. The optimization was
guided by the analysis of the thermal stability of the protein
under various conditions, using two different methods that
monitor the unfolding of proteins as the temperature is
raised. The inflection point/transition between folded and
unfolded state serves as a quantitative measure of the melt-
ing temperature (Tm). Differential scanning fluorimetry
(DSF) is an indirect method as it measures the exposure of
hydrophobic regions of the protein via a fluorescent
reporter dye, while intrinsic differential scanning fluorime-
try (nanoDSF, nDSF) directly monitors the intrinsic fluo-
rescence of the protein at 350 and 330 nm, i.e. changes in
the environment of tryptophan and tyrosine residues.
The thermal stability of tcFPPS was evaluated by DSF in
TRIS and HEPES buffers at pH (6.5, 7.0, 7.5, and 8.0;
Figure 1a) and at different salt concentrations (data not
shown). The experiments revealed that the enzyme was most
stable in the acidic buffer with a relatively high ionic strength
(75 mM salt). The protein was subsequently stored in 25 mM
TRIS–HCl buffer at pH 6.5 and 75 mM NaCl, supplemented
with 1 mM tris(2-carboxyethyl)phosphine (TCEP). nDSF
analysis confirmed that the buffer selected for storage of
tcFPPS was suitable also for non-frozen samples. The Ti of a
sample kept at 4C for 1 week after thawing was only
reduced by 0.1C compared to a freshly thawed sample (48.6
and 48.5C, respectively, Figure 1b).
DSF was also used to evaluate the effect of additives
in the standard buffers used for SPR experiments on the
stability of tcFPPS (Figure 1c). The experiments showed
that the enzyme was relatively stable under these condi-
tions, with an inflection point for thermal denaturation
of the protein at around 44C. It increased by 2C when
TCEP was included in the standard buffer, whereas it
was slightly reduced (ΔT = 1C) when Tween20 was
included. Finally, the stability of tcFPPS in sodium ace-
tate pH 5.0, used as preconcentration solution for immo-
bilization on sensor surface was also performed by nDSF
analysis (Figure 1d). It confirmed that the protein was
structurally intact also at these conditions.
2.3 | Evaluation of folding and structural
homogeneity of tcFPPS
To further confirm that the produced tcFPPS had well-
defined regions of secondary structure, as expected from a
properly folded protein, circular dichroism (CD) analysis was
performed.17 The protein sample was diluted in water to
avoid high background absorption from buffers at wave-
lengths below 240 nm. The CD spectrum showed a high
peak around 190 nm, while two negative peaks were seen at
210 and 222 nm (Figure 2a). The spectrum was interpreted
as a folded structure dominated by alpha-helices, small beta-
turns and 20% random coil, in accordance with a properly
folded protein as indicated by the crystal structure.16
The quaternary structure and homogeneity of the
purified protein was evaluated by dynamic light scatter-
ing (DLS). The technique estimates the molecular weight
and size distribution of the protein via measurements of
its diffusion in solution over time.18 A “distribution by
volume analysis” of the protein (stock solution) indicated
that there was essentially only a single species of protein
present (Figure 2b). The hydrodynamic diameter of the
protein was estimated to be 7.14 nm, corresponding to
the molecular weight of a dimer (84 KDa).
2.4 | Evaluation of tcFPPS activity
An enzymatic assay for evaluating the catalytic activity of
tcFPPS continuously by bioluminescence was developed
(Figure 3). The three-enzyme coupled assay (Figure 3a)
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monitored the amount of pyrophosphate (PPi) released
upon the synthesis of FPP, via two serial detection steps
that convert formed PPi into a light signal. In the first
detection step, the enzyme pyruvate phosphate dikinase
(PPDK) uses PPi to form pyruvate and ATP from pho-
sphoenol pyruvate (PEP) and AMP.19,20 In the second
detection step, luciferase uses the produced ATP and
molecular oxygen to convert luciferin into oxyluciferin,
with the concomitant release of light. The PPi released
also in this step is recycled and used by PPDK to produce
ATP, making the assay more stable. The reaction
conditions were optimized with respect to the different
requirements of the three enzymes involved (tcFPPS,
PPDK, and luciferase). All three enzymes were catalyti-
cally active in a HEPES buffer at pH 7.0. Although both
luciferase and FPPS require Mg2+ for activity, it was possi-
ble to use an EDTA-containing reaction buffer optimized
for luciferase stability, as both luciferase and FPPS were
functional under the reaction conditions used.
The luminescence signal of the reaction mixture
increased linearly for over 90 s in the presence of tcFPPS
but not in its absence (Figure 3b). The initial rate was
FIGURE 1 Thermal shift analysis of Trypanosoma cruzi farnesyl pyrophosphate synthase (tcFPPS) stability in different buffers. (a) Differential
scanning fluorimetry (DSF) analysis of effect of storage buffer composition: 25 mM TRIS (blue) and 25 mM HEPES (orange) at pH 6.5, 7.0, 7.5, and
8.0 (from dark to light shade). (b) nDSF analysis of stability of tcFPPS stored in 25 mM TRIS–HCl buffer at pH 6.5 and 75 mM NaCl, supplemented
with 1 mM TCEP at 4C. Freshly thawed sample (solid line) and after 1 week from thawing (dashed line). (c) DSF analysis of effect of additives in the
running buffer used for surface plasmon resonance analysis (10 mMHEPES, 150 mM NaCl, 3 mM Mg2+-acetate) on the stability of tcFPPS. Inclusion
of 1 mM TCEP alone (bottom, medium green), 0.05% Tween20 alone (top, dark green), or both 1 mM TCEP and 0.05% Tween20 (middle, light
green). (d) nDSF analysis of stability of tcFPPS in sodium acetate pH 5.0 (used as preconcentration solution for immobilization on sensor surface).
Freshly protein sample (solid line) and sample thermally inactivated through incubation at 92C for 5 min (red dotted line)
FIGURE 2 Assessment of folding
and structural homogeneity of produced
Trypanosoma cruzi farnesyl
pyrophosphate synthase (tcFPPS).
(a) Circular dichroism spectrum of
tcFPPS diluted in water to
0.2 mg/mL. (b) Dynamic light scattering
analysis of stock solution
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proportional to the concentration of tcFPPS and IPP/GPP
but was not affected by changes in the concentration of
PEP or PPDK (Table 1). This confirmed that the pro-
duced enzyme was catalytically active and that the rate-
determining step of the reaction was catalyzed by tcFPPS
under these conditions.
2.5 | Fragment library screening against
tcFPPS
Two methods were used to screen a fragment library
against the produced tcFPPS, the first employed an SPR
biosensor and the second DSF. These methods are comple-
mentary and therefore suitable for orthogonal validation
of hits. Ninety structurally diverse fragments with a broad
chemical diversity and high solubility were selected for the
screening.
An SPR assay suitable for screening of fragments
against tcFPPS was developed by immobilizing the protein
by amine coupling (Figure 4a). The level of immobilization
was kept to approximately 3,000 RU, theoretically ade-
quate for the detection of interacting fragments. A control
immobilization with thermally inactivated FPPS was
FIGURE 3 Analysis of catalytic activity of Trypanosoma cruzi farnesyl pyrophosphate synthase (tcFPPS). (a) Scheme of coupled
enzymatic assay for analysis of tcFPPS activity. tcFPPS reaction: Synthesis of farnesyl pyrophosphate (FPP) and pyrophosphate (PPi) from
geranyl pyrophosphate (GPP) and isopentenyl diphosphate (IPP). Pyruvate phosphate dikinase (PPDK) reaction: Conversion of PPi into ATP
using AMP, and with the associated conversion of phosphoenol pyruvate (PEP) into pyruvate (Pyr) and phosphate (PO4
2−). Luciferase
reaction: ATP drives the conversion of luciferin into oxyluciferin using O2 and Mg
2+. This is followed by the spontaneous reaction that
generates light. AMP and pyrophosphate are recycled into the PPDK reaction. (b) Enzymatic activity monitored continuously as the increase
in luminescence (relative light unit, RLU) as a function of time (in seconds) in a standard assay mixture consisting of 10 nM tcFPPS, 0.32 U
PPDK, luciferase/luciferin reaction kit containing Mg2+, 0.5 mM PEP, 1 μM GPP and 2.5 μM IPP, 0.4 mM AMP in HEPES-EDTA at pH 7.0.
(c) Activity of tcFPPS immobilized to a full sensor chip surface on the bench. Reagents were pipetted directly to the chip surface. Samples
were extracted every 10 s, and the luminescence was measured according to the standard procedure in microplates. Activities were
determined directly after immobilization (top, circles), after a 2-min incubation with 40 μM risendronate (middle, squares), and after a 2-min
incubation with guanidinium-HCl (bottom, triangles)
TABLE 1 Effect of variations in enzyme and substrate
concentrations on catalytic rate of coupled FPPS reaction
Concentration Rate (RLU/sec)
tcFPPS (nM) 0 1.8 ± 0.5
1 8.1 ± 0.1
5 46 ± 13
10 108 ± 2
IPP/GPP (μM) 0:0 1.2 ± 0.9
2.5:1 108 ± 2
25:25 844 ± 90
PEP (mM) 0.01 106 ± 8
0.5 108 ± 2
1 117 ± 1
PPDK (U) 0.32 108 ± 2
0.6 113 ± 10
Note: tcFPPS was 0, 1, 5, and 10 nM, 1 μM GPP, 2.5 μM IPP, and 25 μM. PEP
was 0.01, 0.5, and 1 mM. PPDK was 0.32 and 0.6 U. The standard
concentrations are highlighted in bold. Errors are standard deviations, based
on triplicate measurements.
Abbreviations: GPP, geranyl pyrophosphate; IPP, isoprenyl pyrophosphate;
PEP, phosphoenol pyruvate; PPDK, pyruvate phosphate dikinase; tcFPPS,
Trypanosoma cruzi farnesyl pyrophosphate synthase.
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performed to confirm that the protein needed to be struc-
turally intact for immobilization (Figure 4b). The unfolded
protein is not efficiently preconcentrated on the surface,
and only low levels were immobilized even after a longer
coupling period. Problems with the structural integrity of
a protein sample could therefore be detected already at the
stage of immobilization.
The screening conditions were based on a standard
biosensor buffer, that is, HEPES at pH 7.4, supplemented
with 150 mM NaCl and TCEP, carefully selected with
respect to enzyme stability/functionality over time (eval-
uated as described above), physiologically relevant ionic
strength and reducing environment. Experiments with
three bisphosphonates (risendronate, ibandronate, and
alendronate) showed that they interacted with the sur-
face but resulted in secondary effects (not shown). This
indicates that the immobilized enzyme was functional,
although the compounds were not suitable as reference
compounds for screening or characterization of hits.
To confirm that the immobilized enzyme was func-
tional, it was also manually immobilized to the full sensor
chip surface on the bench (i.e., outside the instrument),
using the same procedure as in the instrument (see above).
The catalytic activity was then determined using a modi-
fied luminescent assay. The immobilized enzyme was
found to be catalytically active, while its activity was sig-
nificantly lower in the presence of a bisphosphonate inhib-
itor and lost completely after exposure to guanidinium
hydrochloride (Figure 3c).
Two independent SPR screening experiments were
performed, using new surfaces prepared specifically for
each screen. As there was no suitable reference com-
pound available, the threshold for definition of hits was
set to 30% of the theoretical Rmax of each compound. To
enable the identification of fragments selective for the
Mg2+-bound active form of tcFPPS, the experiments were
performed with and without Mg2+ in the buffer, with the
experiment without Mg2+ serving as a negative reference.
Fragments interacting with the target in the presence of
Mg2+ were thus prioritized as hits.
The SPR-based screen in the presence of Mg2+ initially
identified 16 hits, that is, 18% (Figure 5a), of which five
(5%) were confirmed by analysis of a concentration series.
Hits were considered to be validated if the sensorgrams
were of good quality and there was a clear concentration
dependence. The five hits were selected although they also
interacted with tcFPPS in the absence of Mg2+. The
FIGURE 4 Typical sensorgrams
for preparation of a Trypanosoma cruzi
farnesyl pyrophosphate synthase
biosensor surface used for fragment
library screening. Sensor surface with
active protein (a), and reference surface
with thermally inactivated protein (b)
FIGURE 5 Data from primary screening of fragment library
against Trypanosoma cruzi farnesyl pyrophosphate synthase using
surface plasmon resonance (SPR) and differential scanning
fluorimetry, in the (a) presence of Mg2+ and (b) absence of Mg2+.
Data represent normalized SPR signals (RNORM = RU/Rmax).
Fragments with signals above the 0.3 RNORM threshold in (a) were
defined as hits. Final hits (Compounds 1–5) are shown as dark pink
filled circles, 11 additional initial hits are shown as shaded pink
circles. These hits have the same coloring in (b)
FIGURE 6 Structural stability of Trypanosoma cruzi farnesyl
pyrophosphate synthase in the presence of Fragments 1–5
(colored), DMSO reference (black) visualized as differential
scanning fluorimetry-based melting curves. ΔTm below −1C of
the control is shaded
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observation that 25 fragments were above the threshold in
the absence of Mg2+ (Figure 5b) suggested that nonspecific
binding occurred to a higher degree without Mg2+, indicat-
ing that Mg2+ is important for the structural integrity of
FPPS, not only for forming a catalytically competent active
site. This interpretation is supported by the much higher
signals for the hits in the absence compared to in the pres-
ence of Mg2+. Consequently, only the five hits confirmed
in the replicate screen were considered relevant and were
selected for further studies.
Several independent screens were also performed by
DSF in the presence and absence of Mg2+. The threshold
for hit selection was set to ΔTm > ±1C, relative the ref-
erence Tm obtained by injecting DMSO alone. Most
fragments reduced the Tm. However, 35 hits were identi-
fied both in the presence (Figure 5a) and absence of Mg2+
(Figure 5b). Only nine were unique to each condition as
26 fragments were identified under both conditions.
When comparing the results from the SPR and the
DSF screens, it was found that there was a limited over-
lap between the hits (Figure 5). Of the five hits selected
on the basis of SPR experiments, only two resulted in
ΔTm > 1C when analyzed by DSF in the presence of
Mg2+ (Fragments 1 and 5 in Figure 6).
The interaction characteristics of the five selected hits
were explored using the SPR biosensor assay. Analysis of
a series of concentrations diluted from a maximal con-
centration of 250 μM resulted in the rapid interaction
FIGURE 7 Analysis of interactions
between Fragments 1–5 and
Trypanosoma cruzi farnesyl
pyrophosphate synthase, using a surface
plasmon resonance biosensor assay.
Sensorgrams for threefold dilution series
of fragments, starting at 250 μM. For
Fragment 5, both the original (5A) and
the bulk corrected sensorgrams (5B) are
shown
FIGURE 8 Steady-state analysis of interactions between Fragments 1–5 and Trypanosoma cruzi farnesyl pyrophosphate synthase (data
from Figure 7). Solid curves are theoretical saturation curves based on nonlinear regression analysis of reference subtracted and molecular
weight normalized (RNORM = RU/Rmax) data and a simple 1:1 interaction. The dashed lines represent the slopes of the graphs at low ligand
concentrations, from which the binding efficiency (BE) was estimated. The saturation curve for Fragment 5 was based on bulk corrected
sensorgram (5B in Figure 7)
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kinetic profile typical for fragments (Figure 7). Fragment
5 showed secondary effects that could not be eliminated
by accounting for a large signal jump at the beginning
and end of the injection, potentially due to bulk effects
(Figure 5a, b, respectively). The relationship between
steady state signals (i.e., representing the complex con-
centration) and fragment concentrations were analyzed
from report points early during the injection, in order to
reduce complications from such secondary effects. The
relationships were linear or only slightly curved for all
fragments, as anticipated for very weak interactions
(Figure 8). Although it was technically possible to use the
graphs to estimate KD values and calculate corresponding
ligand efficiencies (LE) (Table 2), the actual numbers are
not relevant since the experiments were performed under
conditions far from steady state. KD values in the mM
range represent very weak interactions with the target
and extracted signals may be flawed by effects not related
to the interaction of interest. In order to rank the frag-
ments on their ability to interact with the target at low
concentration, before secondary effects may dominate
the signal, the binding efficiency (BE) was therefore also
calculated.21 The analysis indicated that Fragment 5 binds
most efficiently with the target, followed by Fragments
4 and 2.
2.6 | Inhibition analysis
The activity of FPPS was analyzed in the presence of the
two best hits (Fragments 4 and 5) at 250 μM. However, no
effect was detected. In a control experiment, risendronate
inhibited the enzyme completely when tested at 10 μM.
3 | DISCUSSION
To enable the detection of fragments interacting weakly
with tcFPPS using biophysical methods, the fundamental
first step for FBLD, it was essential to optimize the
experimental procedures for producing high-quality pro-
tein and conditions that keep it stable and functional
over time. A panel of orthogonal methods was conse-
quently applied for analysis of the produced tcFPPS.
3.1 | Production and handling of tcFPPS
and quality of produced protein
Functional tcFPPS was successfully produced and condi-
tions suitable for storage and handling for functional
studies and screening were identified. Problems with the
initially produced enzyme were attributed to suboptimal
conditions for storage and handling. The combination of
biophysical methods used confirmed that the revised pro-
tocols resulted in the production of an enzyme that was
soluble (nonaggregated), in the form of a dimer (84 kDa),
folded with secondary structure features in accordance
with the crystal structure, and stable over time.16
The conditions selected for functional analysis were
selected also with respect to physiological relevance.
Some of the initial biophysical experiments were per-
formed using buffers suboptimal for functional studies
but provided information concerning structural charac-
teristics required at the time. Most important, all buffers
used for functional studies contained the catalytic cofac-
tor Mg2+ and had a pH of 7.0 or 7.4, close to the cytosolic
pH reported for Trypanosoma Cruzi, that is, 7.33 for
epimastigotes and 7.35 for trypomastigotes.22
3.2 | Catalytic assay
The functionality of the enzyme was confirmed by a
novel continuous catalytic assay. The conditions for the
coupled assay were optimized with respect to the three
enzymes involved. EDTA was included in the buffer and
the pH was set to 7.0 although this was suboptimal for
tcFPPS, being dependent on Mg2+ and being maximally
active at pH 8.4 However, these conditions were consid-
ered to be optimal for the luciferase23 and PPDK activi-
ties.24 The resulting assay was found to be dependent on
the concentration of tcFPPS, confirming that it represen-
ted the rate limiting step of the coupled reaction.
The sensitivity of the developed assay is high, as dem-
onstrated by the possibility of detecting activity with as
little as 1 nM enzyme (not shown). It is faster than the
radiometric assay currently in use4,13 and very practical
as it is homogeneous and measurements can be per-
formed in microtiter plates without requiring separate
steps for incubation, washing, and so on. The assay is
useful both for confirming that the enzyme employed for
screening is functional and for discriminating binders
TABLE 2 Interaction parameters for selected hits
Fragment
KD
(mM) LE (kcal/mol × HA)
BE
(RNORM/M)
1 0.9 0.3 1.2
2 0.2 0.3 2.0
3 0.3 0.2 1.2
4 0.3 0.4 3.7
5 0.2 0.3 5.3
Note: KD and binding efficiency (BE) values were estimated from the data
visualized in Figure 8. Ligand efficiency (LE) was calculated from KD values.
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from inhibitors, which can be difficult when screening
fragments using binding assays. Although risendronate
confirmed that the assay can be used to detect inhibition,
the identified hits did not show any effect when tested at
250 μM, close to their estimated KD values. Testing at
higher concentrations was not attempted since they
would potentially cause side effects by interactions with
other components in the assay mixture.
The thermal stability of tcFPPS was sensitive to pH,
with a slightly higher stability at pH 6.5 than 7.0 and 7.5.
It is marginally below the pH indicated for physiological
conditions (of 7.3–7.35).22 Furthermore, it has been previ-
ously demonstrated that the catalytic activity of the
enzyme increases with increased pH, with a maximum at
pH 8.0.4 Although the pH-optimum of activity and stabil-
ity of enzymes are often correlated, there are cases which
would suggest just the opposite.25 It can be speculated
that there is an advantage, maybe from a regulatory per-
spective, that the pH optimum for stability is different
from the optimum for activity.
3.3 | Fragment library screening
The suitability of the produced enzyme for screening of a
fragment library using an SPR-biosensor based assay was
validated. The hit rate of 5% is acceptable, and the com-
pounds are of interest to follow up using conventional
fragment-based evolution strategies.
In addition, the results highlight the importance of
using high-quality protein and conditions ensuring that
the target is functional in the screening experiment.
Often this is monitored by using reference compounds
that define the degree of functionality of the sensor sur-
face. But in the absence of suitable reference com-
pounds this is not possible. The functionality of the
immobilized protein was therefore evaluated by other
means. As a first test, it was confirmed that the low pH
conditions (5.0) required for immobilization did not
destroy the structural integrity of the protein. The
immobilization procedure revealed problems with the
structural integrity of a protein sample, and surfaces
perceived to be of poor quality were therefore not used.
Moreover, immobilization of the protein did not destroy
its activity. It was shown to be catalytically active and
sensitive to inhibition by bisphosphonates and denatur-
ation by guanidium hydrochloride.
The observation that a larger number of compounds
bound in the absence of Mg2+ indicated that the degree of
nonspecific binding is higher when the cofactor is not pre-
sent, consistent with its structural effects. It was therefore
possible to use the screen performed in the absence of
Mg2+ as a negative control, but where the identified
binders were not selected unless they also bound to the
functional surface, instead of selecting compounds that
only bound the functional surface, as was the original
plan. The hits therefore appear to be specific for the
functional form of the protein.
The differences in the results from SPR and DSF can
be attributed to the very different principles for selecting
hits. DSF only detects hits that interact in regions of the
protein which are involved in the folding/unfolding pro-
cess. The low affinity of fragments also influences the
potential to detect binding. The hits from the screen in
the presence of Mg2+ all exhibited negative ΔTm, while in
the screen in the absence of Mg2+ hits with positive ΔTm
were detected. This supports that the structural integrity of
the protein under the two conditions are very different,
influencing the results also with DSF. Artifacts with both
false-positive and false-negative are well documented for
this technique when applied to fragment screening.11
Due to the high uncertainty in quantifying low affin-
ity interactions, for which saturation is not reached
within a concentration range where the compound is sol-
uble, or when the influence of interactions with second-
ary sites makes interpretations difficult, the BE was also
calculated as a parameter to rank hit compounds.21 It is a
simple procedure where the initial slope of the curve
describing the relationship between the concentrations
of complex at different ligand concentrations (Figure 8)
is used as a measure of the ligand to bind to the protein
without assuming a mechanistic model or stoichiome-
try. Complexities due to multiple weak interactions
(nonspecific binding) or other effects therefore do not
come into play. This is an advantage at this stage of hit
selection.
3.4 | Conclusions
This first study of FPPS as a target for FBLD has revealed
that it can be used for fragment library screening and hit
validation using an unconventional referencing, suitable
when reference compounds are not available.
4 | MATERIALS AND METHODS
4.1 | Fragment library
Ninety fragments were selected from a 96-membered
library designed to have compounds with a large chemi-
cal diversity and high solubility, suitable for crystallo-
graphic driven lead discovery (Frag Xtal Screen, JENA
Bioscience) were used.26 The screening hits were (Jena
compound number, CAS ID): Fragment 1: J3, CAS
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838813-44-8; Fragment 2: J16, CAS 1311649-76-9; Frag-
ment 3: J42, CAS 501442-73-5; Fragment 4: J66, CAS
95-25-0; Fragment 5: J92, CAS 7659-29-2.
4.2 | tcFPPS expression and purification
A plasmid containing the gene for N-terminally His-
tagged tcFPPS was obtained from Novartis. It was used to
transform 100 μl of E. coli BL21 (DE3) cells subsequently
plated on agarose-LB solid medium supplemented with
kanamycin. Bacterial clones were grown in 2XTY medium
containing 50 μg/mL kanamycin at 37C, until OD600 of
0.6. The system was cooled to 18C and growth continued
until OD600 1.0, when 1 mM of isopropyl β-D-
thiogalactoside was added. The cells were harvested by
centrifugation after an additional 16 hr of growth at 18C
and frozen at −80C. After thawing, the pellet was
resuspended in phosphate-buffered saline (PBS; Medicago
AB, Uppsala, Sweden) pH 7.4 supplemented with protease
inhibitors (cOmplete™ EDTA-free, Roche), 10 μg/mL
DNAse (bovine pancreas, Grade II, Sigma-Aldrich),
500 μg/mL lysozyme (chicken egg white, Grade VI, Sigma-
Aldrich), 4 mMMgCl2 (Sigma-Aldrich), and 5 mM imidaz-
ole (Sigma-Aldrich). The volume of the supplemented PBS
buffer was 10 times more than the volume of the pellet
itself. Cells were then lysate using a French press (1.7 kPSI)
and centrifuged at 18000 rpm for 45 min (4C).
The supernatant was filtered through a 0.22 μm
Millipore filter (Ahlstrom Munksjö, Helsinki, Finland)
and loaded onto a Nickel-chelated agarose affinity col-
umn (Qiagen) that had been equilibrated with the same
PBS buffer with 5 mM imidazole. Elution of the His-
tagged protein was performed using an increasing con-
centration of imidazole, as described by the manufacturer
protocols.27 After concentration via centrifugation using
a filter with a cut-off 30 kDa (Amicon Ultra-15), the pro-
tein was exchanged to a buffer containing 25 mM Tris,
75 mM NaCl, and 1 mM TCEP pH 6.5 using PD10 col-
umns (GE Healthcare). Aliquots of the enzyme were then
flash-frozen in liquid nitrogen and stored at −80C.
The purity of the protein was estimated by SDS-PAGE
and the concentration by NanoDrop ND-1000 Spectro-
photometer (Marshall Scientific).
4.3 | Thermal shift assays
The thermal stability of tcFPPS was evaluated under dif-
ferent conditions using both indirect and direct thermal
shift assays:
DSF. An indirect thermal shift analysis was per-
formed using SYPRO Orange and a QuantumStudio
3 instrument (ThermoFisher Scientific). Two different set
ups were used:
The stability of tcFPPS was analyzed by adding pro-
tein (0.3 mg/mL) to specified buffers, supplemented with
SYPRO Orange dye, to a total volume of 20 μL/well. Two
different buffering agents (TRIS and HEPES) were tested
at 25 mM and different pH values (6.5, 7.0, 7.5, and 8.0)
and salt (NaCl from 25 to 200 mM, MgCl2 from 0 to
5 mM) concentrations. A thermal ramp of 0.05C/s was
applied from an initial temperature of 20C to a final
temperature of 95C, the initial and the final tempera-
tures were maintained for 1 min. The system was then
cooled down to 20C at a speed of 1.6C/s. This setup
was applied for identifying suitable storage conditions
for tcFPPS and for verifying the stability of the protein
in the running buffer chosen for SPR-based
experiments.
A fragment library was screened against 0.21 mg/mL
tcFPPS in the screening buffer (10 mM HEPES pH 7.4,
1 mM TCEP, supplemented with 3 mM MgCl2 and 1X
conc fluorescent dye) in a total volume of 20 μL/well.
Each fragment was added to a final concentration
500 μM (2% DMSO). Control experiments with 1 and 2%
DMSO were also performed. A thermal ramp of 1C/min
was applied from a starting temperature of 20–95C, both
held for 1 min, as described by Niesen et al.28
nDSF: Intrinsic protein fluorescence was monitored
over a range of temperatures using a Tycho NT6 instrument
(Nanotemper Technologies). Two capillaries were filled with
identical samples of 7 mg/mL tcFPPS in storage buffer
(25 mM Tris pH 6.5, 75 mM NaCl, 1 mM TCEP), directly
after thawing from −80C storage. Duplicate samples that
had been kept at 4C for a week after thawing were ana-
lyzed in the same way. An experiment where the stability of
tcFPPS in sodium acetate pH 5.0 (used as preconcentration
solution for immobilization on sensor surface, see below)
was carried out in the same way.
The fluorescence was monitored at 330 and 350 nm
during a thermal ramp from 35 to 95C. The data were
plotted as a derivative in order to get the inflection point
for the shift of intrinsic fluorescence in the experiments.
It was used to calculate the inflection temperature (Ti).
4.4 | Circular dichroism
The tcFPPS stock solution was taken from −80C stor-
age and thawed directly before analysis. It was diluted
to a final concentration of 0.2 mg/mL in water. Spectra
were recorded from 190 to 250 nm in a 0.2 mm cuvette,
using a JASCO 1.500 instrument and analyzed with
Spectra Analysis software. Online software
DichroWeb29,30 was used for the deconvolution of the
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spectra with Contin-LL analysis program (Provencher &
Glockner method).31
4.5 | Dynamic light scattering)
A stock sample of tcFPPS was taken from −80C storage
and thawed directly before analysis. A capillary was filled
with the solution of tcFPPS and DLS analysis was per-
formed using Zetasizer Ultra (Malvern Panalytical). The
data were analyzed using the Zs Xplorer software
(Malvern Panalytical), enabling the estimation of the
hydrodynamic radii of the protein using the Stokes-
Einstein equation and the particle size distribution based
on the volume of the particles in each size range.32
4.6 | Catalytic assay
The activity measurements were carried out in 96-well
microplates (Greiner bio-one) at 25C. The standard
assay mixture consisted of 10 nM tcFPPS, 0.32 U PPDK
(Kikkoman, Osaka, Japan), 40 μL of a luciferase/luciferin
assay kit containing luciferase, D-luciferin, stabilizers
and Mg2+ (ARSL 11-501-TP, BioThema, Handen, Swe-
den), 1 μM GPP and 2.5 μM IPP (Echelon Inc., Salt Lake
City, Utah), 0.5 mM PEP (Sigma-Aldrich), 0.4 mM AMP
(Sigma-Aldrich), made up to a total volume of 200 μL in
HEPES-EDTA buffer at pH 7.0 (BioThema, Handen, Swe-
den). The reaction was started by adding the IPP/GPP
substrate mixture. The increase in luminescence was
measured continuously in relative light units (RLU)
using a SpectraMax iD5 Multi-Mode Microplate reader.
Control experiments with different concentrations of
tcFPPS, PPDK, GPP/IPP, and PEP were performed in
order to confirm that all enzymes were active and the
tcFPPS reaction was the rate limiting step under the
conditions used.
The luminescent microplate assay was also used to mea-
sure the activity of the enzyme on an entire chip surface.
The same immobilization procedure as described below
for the SPR biosensor analysis was used, but manually
pipetting the solutions onto the entire sensor surface with
the chip outside the instrument (on the bench). Substrates
(at concentration as above, but in SPR running buffer) were
pipetted to the chip surface (see below). Samples of 10 μL
each were taken every 10 s (10, 20 30, 40, and 50 s) and
added to a standard reaction mixture in micro titer plate
wells containing 0.32 U PPDK, 0.5 mM PEP, 0.4 mM AMP
in HEPES-EDTA buffer pH 7.0. Luciferin/luciferase from
the assay kit (40 μL) was then added to each well, and
the luminescence signal was measured in RLU using a
SpectraMax iD5 Multi-Mode Microplate reader.
4.7 | SPR biosensor analysis
Analysis of direct interactions between tcFPPS and fragments
was performed with a Biacore T200 instrument
(GEHealthcare) at 25C. tcFPPSwas immobilized to a level of
approximately 3,000 RU on CM5 Series S sensor chip using
standard procedures for amine coupling.33 The running buffer
used for immobilization, screening, and interaction analysis
consisted of 10 mM HEPES, 150 mMNaCl, 3 mM Mg2+-ace-
tate, 1 mM TCEP, and 0.05% Tween20, supplemented with
1% DMSO for screening and interaction analysis. A reference
screen was performed on a different surface from the screen,
using the same buffer withoutMg
2+
. A blank reference surface
was activated and deactivated and used to detect non-specific
binding of fragments.
Fragments were diluted in running buffer and
injected 250 μM for 60 s at a flow rate of 50 μL/min.
The final DMSO concentration in all buffers used for
screening was 1%. Nonspecific signals were removed by
subtraction of sensorgrams from the reference channel.
Compounds with signals between 30 and 100% of a the-
oretical Rmax were selected as hits. The analysis was
based on report points representing the average signal
5 s before the end of the injection (binding late
[BL] response). The screening was performed with two
different surfaces and 12 fragment hits were selected
for further analysis. BL values were normalized with
respect to the theoretical Rmax of each fragment (as in
Equation [1]), in order to account for differences







The selected fragment hits were validated by analysis
of a three-fold dilution series starting at 250 μM for 60 s at
a flow rate of 50 μL/min. Nonspecific signals were
removed by subtraction of signals from the reference chan-
nel. Solvent corrections were also performed to compen-
sate for differences in DMSO concentrations between the
running buffer and samples. Apparent KD values were esti-
mated by a steady-state analysis based on the BL response





A steady-state analysis based on binding early
response taken 7 s after the start of the injection was also
performed, resulting in estimated KD-values of the same
order for each compound (Table 2).
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Estimated KD-values from report points were used to
calculate the LE for each of the selected hits, according to
Equation (2).
LE=
− RTln KDð ÞnHA
 
1000 kcalmol ×HA
  , ð2Þ
Where R is the gas constant 8.31451 J/molK, T is the
temperature in Kelvin, and nHA is the number of non-
hydrogen atoms in the sample molecules.34
The BE was calculated from steady-state data at dif-
ferent ligand concentrations as the slope of the linear
relationship between complex concentration and ligand
concentrations at very low ligand concentrations.21 This
results in an estimate of how much compound is bound
as a function of concentration, without any assumptions
of the mechanism of binding, number of binding sites or
effects due to limited solubility of fragments at high
concentrations.
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